Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

FGFR3 V555M

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

PD-L1 overexpression + FGFR3 amplification (2)

ALK fusion + MYC amplification + CCND1 deletion + FGFR3 deletion (1)

ER positive + FGFR3 amplification (1)

FGFR2 underexpression + FGFR3 mutation (1)

FGFR3-TACC3 fusion + FGFR3 V555M (1)

IDH wild-type + FGFR3 S249C + TP53 V73fs (1)

TERT C228T + FGFR3 amplification + FGFR3-TACC3 fusion (1)

PD-L1 overexpression + FGFR3 amplification (2)

ALK fusion + MYC amplification + CCND1 deletion + FGFR3 deletion (1)

ER positive + FGFR3 amplification (1)

FGFR2 underexpression + FGFR3 mutation (1)

FGFR3-TACC3 fusion + FGFR3 V555M (1)

IDH wild-type + FGFR3 S249C + TP53 V73fs (1)

TERT C228T + FGFR3 amplification + FGFR3-TACC3 fusion (1)

›

FGFR3 V555M	Multiple Myeloma	FGFR3 V555M	Multiple Myeloma	PD173074 Resistant: D – Preclinical PD173074 Resistant : D	PD173074 Resistant: D – Preclinical PD173074 Resistant : D
FGFR3 V555M	Multiple Myeloma	FGFR3 V555M	Multiple Myeloma	ABSK091 Resistant: D – Preclinical ABSK091 Resistant : D	ABSK091 Resistant: D – Preclinical ABSK091 Resistant : D